Tianjin Pharmaceutical da Ren Tang Group Ltd 2022 Annual Report
Company: Tianjin Pharmaceutical da Ren Tang Group Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: Annual Report
Pages: 218
The report describes strong FY2022 financial performance, with Group revenue increasing 19% to approximately RMB8,249 million. It also records the acquisition of additional NewScen Coast shares, after which the company obtained control and brought the business into the Group. On sustainability, the company assigned a Sustainability task force to oversee reporting and monitor sustainability performance and policy implementation, while identifying energy, water, emissions, waste, occupational safety and diversity as relevant topics.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.